Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.320
+0.100 (4.50%)
At close: May 12, 2025, 4:00 PM
2.430
+0.110 (4.74%)
After-hours: May 12, 2025, 4:26 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $87.40 million as of May 12, 2025. Its market cap has decreased by -73.33% in one year.
Market Cap
87.40M
Enterprise Value
-26.23M
1-Year Change
-73.33%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $87.40M, a decrease of -82.10%. That is a compound annual growth rate of -36.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 83.63M | -69.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |